Kamada Shares Rise

Kamada Shares Rise

Kamada shares were higher 9% in early trade Friday after the company and Kedrion Biopharma said that Kedrab has obtained U.S. Food and Drug Administration approval for passive, transient post-exposure prophylaxis of rabies infection, when given immediately after contact with a rabid or possibly rabid animal. Kedrab should be administered concurrently with a full course of rabies vaccine. Rabies is a life-threatening condition that impacts 40,000 people in the U.S. […]

Read More ˃